These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 23253945)
1. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Mackey S; Paulus M Neurosci Biobehav Rev; 2013 Mar; 37(3):300-16. PubMed ID: 23253945 [TBL] [Abstract][Full Text] [Related]
2. A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine. Mackey S; Stewart JL; Connolly CG; Tapert SF; Paulus MP Drug Alcohol Depend; 2014 Feb; 135():104-11. PubMed ID: 24342420 [TBL] [Abstract][Full Text] [Related]
3. Adverse effects of stimulant drugs in a community sample of drug users. Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780 [TBL] [Abstract][Full Text] [Related]
4. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits. Reske M; Eidt CA; Delis DC; Paulus MP Biol Psychiatry; 2010 Oct; 68(8):762-9. PubMed ID: 20605137 [TBL] [Abstract][Full Text] [Related]
5. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis. Vu NT; Maher L; Zablotska I J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214 [TBL] [Abstract][Full Text] [Related]
6. Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry. Daumann J; Koester P; Becker B; Wagner D; Imperati D; Gouzoulis-Mayfrank E; Tittgemeyer M Neuroimage; 2011 Jan; 54(2):794-801. PubMed ID: 20817105 [TBL] [Abstract][Full Text] [Related]
9. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review. Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090 [TBL] [Abstract][Full Text] [Related]
11. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review. Shadloo B; Amin-Esmaeili M; Haft-Baradaran M; Noroozi A; Ghorban-Jahromi R; Rahimi-Movaghar A East Mediterr Health J; 2017 May; 23(3):245-256. PubMed ID: 28493273 [TBL] [Abstract][Full Text] [Related]
12. Ice in the Outback: the epidemiology of amphetamine-type stimulant-related hospital admissions and presentations to the emergency department in Hedland, Western Australia. Monahan C; Coleman M Australas Psychiatry; 2018 Aug; 26(4):417-421. PubMed ID: 29533079 [TBL] [Abstract][Full Text] [Related]
13. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC). Jafari Giv M Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745 [TBL] [Abstract][Full Text] [Related]
14. Letter in response to: "Stimulant-induced hyperthermia and ice-water submersion: practical considerations". Laskowski LK; Landry A; Vassallo SU; Hoffman RS Clin Toxicol (Phila); 2016; 54(1):71. PubMed ID: 26574142 [No Abstract] [Full Text] [Related]
15. Psychostimulants and epilepsy. Zagnoni PG; Albano C Epilepsia; 2002; 43 Suppl 2():28-31. PubMed ID: 11903480 [TBL] [Abstract][Full Text] [Related]
16. The role of dopamine in the mouse frontal cortex: a new hypothesis of behavioral sensitization to amphetamine and cocaine. Karler R; Calder LD; Thai DK; Bedingfield JB Pharmacol Biochem Behav; 1998 Dec; 61(4):435-43. PubMed ID: 9802839 [TBL] [Abstract][Full Text] [Related]
17. Responding to global stimulant use: challenges and opportunities. Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R Lancet; 2019 Nov; 394(10209):1652-1667. PubMed ID: 31668409 [TBL] [Abstract][Full Text] [Related]
18. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes. Regier PS; Kampman KM; Childress AR Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666 [TBL] [Abstract][Full Text] [Related]
19. Addictiveness of central stimulants. Dackis CA; Gold MS Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121 [TBL] [Abstract][Full Text] [Related]
20. Attenuated Neural Processing of Risk in Young Adults at Risk for Stimulant Dependence. Reske M; Stewart JL; Flagan TM; Paulus MP PLoS One; 2015; 10(6):e0127010. PubMed ID: 26076493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]